Works matching IS 1934662X AND DT 2023 AND VI 131 AND IP 3

Results: 10

The "preexisting condition" invention in American health care: The persistence of a potential insurance nightmare: In this first part of a two‐part series, the uniquely American business model of private health insurance has excluded millions for reasons that have little to do with medicine or biology; the potential return of such exclusions could threaten some of medicine's biggest goals

Published in:

Cancer Cytopathology, 2023, v. 131, n. 3, p. 149, doi. 10.1002/cncy.22686

By:

Nelson, Bryn;
Faquin, William

Publication type:

Article

A distinctive cytomorphological feature of interstitial pneumonia–related lung adenocarcinoma: The potential issues and solutions in practical diagnosis.

Published in:

Cancer Cytopathology, 2023, v. 131, n. 3, p. 198, doi. 10.1002/cncy.22666

By:

Sugiyama, Misaki;
Matsumura, Mai;
Sekiya, Motoki;
Honda, Emi;
Sekine, Akimasa;
Arai, Hiromasa;
Okudela, Koji

Publication type:

Article

Cytopathological assessment is an accurate method for identifying immunophenotypic features and BRCA1/2 mutations of high‐grade serous carcinoma from ascites.

Published in:

Cancer Cytopathology, 2023, v. 131, n. 3, p. 188, doi. 10.1002/cncy.22664

By:

Miceska, Simona;
Škof, Erik;
Novaković, Srdjan;
Stegel, Vida;
Jeričević, Anja;
Grčar Kuzmanov, Biljana;
Smrkolj, Špela;
Cvjetičanin, Branko;
Bebar, Sonja;
Globočnik Kukovica, Marta;
Kloboves‐Prevodnik, Veronika

Publication type:

Article

A simplified molecular method to detect high‐risk HPV using the Aptima HPV assay on head and neck FNA smears.

Published in:

Cancer Cytopathology, 2023, v. 131, n. 3, p. 171, doi. 10.1002/cncy.22662

By:

Gormley, Joseph P.;
Selvaggi, Suzanne M.;
Rehrauer, William M.;
Kucher, Erek T.

Publication type:

Article

Cutoff values of PD‐L1 expression in urinary cytology samples for predicting response to immune checkpoint inhibitor therapy in upper urinary tract urothelial carcinoma.

Published in:

Cancer Cytopathology, 2023, v. 131, n. 3, p. 179, doi. 10.1002/cncy.22661

By:

Chen, Ya;
Fu, Jia;
Li, Zhiyong;
Chen, Qunxi;
Zhang, Jing;
Yang, Yuanzhong;
Yang, Ping;
Wang, Jiayu;
Liu, Zhuowei;
Cao, Yun;
Zhang, Yijun

Publication type:

Article

Utility of high‐risk HPV RNA chromogenic in situ hybridization in cytology smears and liquid‐based preparations from metastatic head and neck squamous cell carcinoma.

Published in:

Cancer Cytopathology, 2023, v. 131, n. 3, p. 165, doi. 10.1002/cncy.22659

By:

Velez Torres, Jaylou M.;
Alkathery, Turky;
Tjendra, Youley;
Zuo, Yiqin;
Kerr, Darcy A.;
Gomez‐Fernandez, Carmen

Publication type:

Article

DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high‐risk group.

Published in:

Cancer Cytopathology, 2023, v. 131, n. 3, p. 158, doi. 10.1002/cncy.22657

By:

Pierconti, Francesco;
Rossi, Esther Diana;
Cenci, Tonia;
Carlino, Angela;
Fiorentino, Vincenzo;
Totaro, Angelo;
Sacco, Emilio;
Palermo, Giuseppe;
Iacovelli, Roberto;
Larocca, Luigi Maria;
Bassi, Pier Francesco;
Martini, Maurizio

Publication type:

Article

Development and validation of an RNA sequencing–based classifier for medullary thyroid carcinoma on thyroid FNA.

Published in:

Cancer Cytopathology, 2023, v. 131, n. 3, p. 154, doi. 10.1002/cncy.22643

By:

Lubin, Daniel J.;
Sadow, Peter M.

Publication type:

Article

Beyond PD‐L1: Assessment of LAG‐3 and other predictive biomarkers in non–small cell lung carcinoma.

Published in:

Cancer Cytopathology, 2023, v. 131, n. 3, p. 151, doi. 10.1002/cncy.22640

By:

Hung, Yin P.;
Mino‐Kenudson, Mari

Publication type:

Article

Issue Information.

Published in:: Cancer Cytopathology, 2023, v. 131, n. 3, p. 145, doi. 10.1002/cncy.22463
Publication type:: Article